• NAD+ at the Stress-Adaptation Decision Point

  2026-08-26

  Nicotinamide Adenine Dinucleotide (NAD+) is more than a redox coenzyme: it connects energy state, enzyme activity, DNA damage responses, and stress adaptation. Building on recent evidence that caspase 3 and caspase 7 support cytoprotective autophagy in human breast cancer cells, this article outlines how translational researchers can use NAD+ to interrogate—and not overinterpret—the cellular stress response.

• Amitriptyline HCl: Neuropharmacology Workflows

  2026-08-26

  A practical guide to using Amitriptyline HCl for concentration–response studies, receptor signaling assays, blood–brain barrier experiments, and disease-relevant neuronal models. It combines product-specific handling guidance with an orthogonal assay strategy inspired by recent lipidomics work in viral neuroscience.

• CSBTA Pharmacokinetics in MASH: PXR and P-gp

  2026-08-25

  This study integrates plasma pharmacokinetics, tissue distribution, cellular transport, metabolism, and regulatory protein expression to explain how MASH-like pathology changes exposure to Corydalis saxicola Bunting total alkaloids. Its findings indicate that repeated treatment can increase systemic and hepatic exposure, with CYP450 enzymes, Oatp1b2, P-gp, and PXR-linked regulation contributing to pharmacokinetic variability.

• HotStart Universal 2X Green qPCR Master Mix

  2026-08-25

  HotStart Universal 2X Green qPCR Master Mix supports reproducible gene expression quantification when studying dosage-sensitive neurodevelopmental mechanisms. This guide connects Green I qPCR chemistry with the NEXMIF overexpression model and shows how assay design, controls, and melt curves strengthen biological interpretation.

• Doxycycline Workflows for MMP and Cancer Research

  2026-08-24

  Build reproducible Doxycycline workflows for metalloproteinase inhibition, antimicrobial controls, and antiproliferative cell assays. This guide also translates a targeted nanoparticle strategy for abdominal aortic aneurysm research into practical comparisons between free compound and lesion-directed delivery.

• ARCA EGFP mRNA for Assay Decision-Making

  2026-08-24

  ARCA EGFP mRNA provides a direct fluorescence-based readout for separating delivery performance from mammalian cell gene expression. This guide develops an assay-interpretation framework that connects reporter controls with pathway-focused cancer research.

• Gramine: Building an Evidence-Grade TNBC Assay

  2026-08-23

  Gramine is an indole alkaloid and ferroptosis inducer for mechanistic triple-negative breast cancer research. This article connects chemical handling, CUL3–MTDH biology, and orthogonal assay design into a reproducible evidence framework.

• HotStart Universal 2X Green qPCR Master Mix Guide

  2026-08-22

  HotStart Universal 2X Green qPCR Master Mix combines hot-start Taq polymerase, Green I fluorescence, and a universal ROX reference dye for real-time PCR gene expression analysis. Its strongest use is reproducible DNA amplification monitoring when primer design, controls, and melt curve analysis are handled as separate quality steps.

• Caspase-3 Fluorometric Assay Kit Workflow

  2026-08-21

  Turn apoptosis experiments into quantitative enzyme-activity data with a rapid DEVD-AFC fluorescence workflow. This guide shows how to use lysate-based caspase-3 measurement to interpret treatment responses, investigate ferroptosis–apoptosis crosstalk, and troubleshoot weak or inconsistent signals.

• DDX3X, Ferroptosis, and KRAS-Driven Lung Cancer

  2026-08-20

  The 2025 Cell Death and Disease study identifies DDX3X as a metabolic dependency in KRAS-driven lung cancer and connects its loss to CBS suppression, impaired cysteine–glutathione metabolism, and ferroptosis. Its mechanistic analysis also supports DDX3X degradation with the PROTAC J10 as a potential strategy for delaying tumor progression, although model-specific and translational limitations remain.

• RNA Pol II Inhibition and Active Apoptotic Signaling

  2026-08-20

  Harper et al. show that RNA Pol II inhibition triggers an active apoptotic response through loss of hypophosphorylated RNA Pol IIA, rather than through passive depletion of transcripts and proteins. Their genetic and pharmacological analyses define the Pol II degradation-dependent apoptotic response, providing a framework for interpreting transcription-targeting therapies and apoptosis assay results.

• Kidney-Targeted mRNA Nanoparticles and Excipients

  2026-08-19

  This 2024 Pace University thesis investigates how excipients can overcome an apparent mRNA loading ceiling in polymeric mesoscale nanoparticles intended for kidney delivery. By comparing charge-modifying and stabilizing excipients with an original formulation, the study connects encapsulation efficiency with particle size, cytotoxicity, pharmacokinetics, cellular uptake, and reporter protein expression.

• Methylprednisolone: From GR Signal to Bone Readouts

  2026-08-19

  Methylprednisolone is a synthetic glucocorticoid receptor agonist that connects cytokine suppression with measurable bone injury phenotypes. This article interprets the compound as a mechanistic research tool, using glucocorticoid-induced osteonecrosis data to guide assay selection, controls, and translational reasoning.

• ABT-199 (Venetoclax): Selective Bcl-2 Inhibitor

  2026-08-18

  ABT-199, also called Venetoclax or GDC-0199, is a potent and selective BCL-2 inhibitor for experimental apoptosis research. Its supplier-reported sub-nanomolar affinity, strong separation from BCL-XL and BCL-w, and lack of MCL-1 activity support studies of the mitochondrial apoptosis pathway in hematologic malignancy models.

• Biomimetic Chromatography Models Lung Drug Permeability

  2026-08-18

  This study compares immobilised artificial membrane liquid chromatography and open-tubular capillary electrochromatography, each coupled with mass spectrometry, as biomimetic tools for modelling pulmonary drug permeability. Its findings show that IAM-LC more closely reflects conventional partitioning and apparent permeability, while OT-CEC provides complementary information about phospholipid composition and drug–membrane interactions.

8627 records 1/576 page Next 12345 下5页 Last page